NEW YORK (GenomeWeb News) – The Flanders government has extended a grant to Peakadilly to speed up development of its biomarker discovery platform, the Belgian company said today.
 
The company plans to use the funds, which total €1.7 million ($2.2 million), to expand relationships with pharma and diagnostic companies and to accelerate development of its own diagnostic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.